Defibrillator

Among patients with in-hospital cardiac arrest, those with COVID-19 had worse rates of survival and return of spontaneous circulation compared with those who did not, according to a research letter published in JAMA Network Open.

Drones successfully delivered automated external defibrillators to the locations of suspected out-of-hospital cardiac arrests, according to a speaker at the European Society of Cardiology Congress.

The FDA announced that it has designated Medtronic’s recall of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators as class 1, the most serious kind.

Citizen responders who were dispatched through a smartphone app and arrived before emergency medical services increased the odds of the patient receiving bystander CPR and bystander defibrillation, researchers found.

The American Heart Association announced the development of a program to teach individuals with physical disabilities who may not be able to perform cardiopulmonary resuscitation themselves how to instruct others in an emergency.

Recent reports of how drone delivery of automated external defibrillators for out-of-hospital cardiac arrest was feasible in simulations for faster CPR initiation was the top story in cardiology last week.

Delivery by drones of automated external defibrillators for out-of-hospital cardiac arrest was feasible and, in simulations, resulted in faster initiation of CPR, researchers reported.

PHILADELPHIA — Individuals who experience out-of-hospital cardiac arrest are less likely to survive to hospital admission on weekends compared with weekdays, according to findings presented at the American Heart Association Scientific Sessions.

PHILADELPHIA — The consideration of left ventricular ejection fraction when diagnosing or making treatment decisions for HF was a topic for debate at the Heart Failure Society of America Scientific Meeting.

PARIS — Early use of an implantable cardioverter defibrillator after primary PCI lengthened survival among high-risk patients with STEMI, according to results of the DAPA trial reported at the European Society of Cardiology Congress.